Assessment of natural Immunoglobulin M/AIM Deficiency in Cardiac Surgery

Assessment of natural Immunoglobulin M/AIM Deficiency in Cardiac Surgery - AIM-CS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00037104

Enrollment

200

Registered

2025-06-06

Start date

2025-01-06

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease Heart valve disease Heart failure

Interventions

Group 1: In patients undergoing elective heart surgery, the concentration of immunoglobulin M (IgM) in the serum is determined on a maximum of eight occasions (before the operation, immediately after

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Elective cardiac surgery

Exclusion criteria

Exclusion criteria: No consent Minority Psychiatric illness with lack of legal capacity Existing infection (e.g. endocarditis) Existing or planned immunosuppression (e.g. organ transplantation, autoimmune diseases) Diseases of the immune system

Design outcomes

Primary

Measure	Time frame
IgM concentration	—

Countries

Germany

Contacts

Public ContactMoritz Benjamin Immohr

Universitätsklinikum Essen, Klinik für Thorax- und Kardiovaskuläre Chirurgie

moritz.immohr@uk-essen.de+4920172386133

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026